FDA Approves Two Lexapro Generics, Three Other Generics for Various Conditions

In recent activity, the Food and Drug Administration approved two generic versions of the depression drug Lexapro, as well as three generic drugs for treating certain lung diseases, tension headaches, and peptic ulcers.

On Sept. 13, Lupin Ltd. announced that FDA has approved a generic version of Forest Laboratories Inc.'s Lexapro (escitalopram oxalate) 5 mg, 10 mg, and 20 mg tablets.

Lexapro is indicated for acute and maintenance treatment of major depressive disorder in adults and adolescents ages 12 to 17 years, said Lupin, which is based in Mumbai. It also is indicated for the acute treatment of general anxiety ...